Rituximab combined with Bruton tyrosine kinase inhibitor to treat elderly diffuse large B-cell lymphoma patients: Two case reports

doi:10.12998/wjcc.v11.i29.7170

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2054)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

120

WORD

HTML

1105

Figures (1-4)

207

Sum=1449

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

147

Download

355

Sum=502

Oct 16, 2023 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 16, 2023; 11(29): 7170-7178
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7170

Full Size Figure Download Figure

Figure 3 After treatment, positron emission tomography-computed tomography showed complete remission of lymphoma.

Citation: Zhang CJ, Zhao ML. Rituximab combined with Bruton tyrosine kinase inhibitor to treat elderly diffuse large B-cell lymphoma patients: Two case reports. World J Clin Cases 2023; 11(29): 7170-7178
URL: https://www.wjgnet.com/2307-8960/full/v11/i29/7170.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i29.7170